Luke Evnin, Ten Percent Owner at Epirus Biopharma, holds 11.13M shares in Epirus Biopharma (Ticker: EPRSQ), holds 6.36M shares in Poniard Pharmaceuticals (Ticker: PARD), holds ― shares in Syndax Pharmaceuticals (Ticker: SNDX). Most recently, Luke Evnin Sold ― shares of Epirus Biopharma on Oct 28, 2011 for an estimated value of 760.97K.
Luke Evnin latest transaction was an Informative Sell of $760.97K.
What was Luke Evnin's most profitable transaction?
Luke Evnin’s most profitable transaction was an Informative Buy of PCRX stock on November 22, 2011. The return on the trade was 114.10%.
What is Luke Evnin's role in Epirus Biopharma?
Luke Evnin's role in Epirus Biopharma is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.